LIVE CONFERENCE:  Available until 5/31/24

ENDURING CONFERENCE: Available until 7/31/24

1. Create an account and fill out your profile using the same email address that you used to register for the conference. (Note: to create an account you will click the “Sign up now” button)

2. Select the number of credits you earned during the live conference. To calculate your credits, click here

3. Click “Save and continue to Evaluation”

4. Once you have filled out the evaluation form, click “Submit Evaluation”

5. If you need to claim pharmacology credit, you will be able to click on the “Claim ANCC-APRN Certificate button. Screenshot is below

2024 Contraceptive Technology Virtual Conference

  • April 25, 2024
  • Jointly provided by Partners for Advancing Clinical Education (PACE) and American Sexual Health Association
  • Enduring activity available May 6, 2024 – June 31, 2024

Target Audience

This activity is intended for physicians, registered nurses, physician’s associate, physician assistant, nurse practitioner, other APRN.

Educational Objectives

Upon completion of this activity, participants should be able to:

OBJECTIVE 1
Explain how to address contraception needs and preferences for clients with chronic medical conditions; lupus, obesity, bleeding disorders, and cardiac conditions.
OBJECTIVE 2
Using patient centered language, describe 2 management options for clients who experience unacceptable bleeding.
OBJECTIVE 3
Demonstrate inclusive, sensitive care with individuals identifying as a sexual or gender minority. 
OBJECTIVE 4
List 3 health advantages for individuals using fertility-awareness based methods correctly.
OBJECTIVE 5
Discuss evidence-based treatments for gonorrhea, trichomonas, chlamydia, and syphilis.

Disclosure of Conflicts of Interest

PACE requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to PACE policies. Others involved in the planning of this activity have no relevant financial relationships.

NameRoleConflicts of INterest
Anne Burke, MD
Johns Hopkins University School of Medicine & Bloomberg School of Public Health
FacultyMerck – Researcher
Patty Cason, NP
Envision SRH, UCLA School of Nursing
Faculty and plannerMerck – speaker on non-branded topic
Sebela Women’s Health – Consultant
Organon – Speaker/ Trainer
Carrie Cwiak, MD
Emory University School of Medicine
FacultySebela Women’s Health -researcher
Springer -Textbook on contraception royalties, patent beneficiary
MIles Harris, NP
UC Davis Health
FacultyHas no relevant financial relationships with ineligible companies to disclose
Debbie Kowal
Contraceptive Technology Communications, Inc.
FacultyHas no relevant financial relationships with ineligible companies to disclose
Chance Krempasky, FNP-BC WHNP-BC AAHIVS
Callen-Lorde Community Health Center
FacultyHas no relevant financial relationships with ineligible companies to disclose
Jeanne Marrazzo, MD, MPH, FACP, FIDSA
Internal Medicine, Infectious Diseases
FacultyGSK – Other
Anita Nelson, MD
David Geffen School of Medicine at UCLA
FacultyViatris Pharmaceuticals Inc- Researcher
Sumitomo Pharma America, Inc – Researcher
Organon & Co, Co Ltd – Researcher
Sebela Women’s Health – Researcher
Bayer – Advisor, Speaker and Consultant
Mayne Pharmaceutical –Advisor, Speaker and Consultant
Merck – Researcher
Organon & Co – Consultant, Advisor, Speaker 
Exeltis USA, Inc – Consultant, Advisor, Speaker 
Sumitomo Pharma America – Consultant, Advisor, Speaker 
Lola Pellegrino, NP
Callen-Lorde Community Health Center
FacultyHas no relevant financial relationships with ineligible companies to disclose
Rachel Peragallo Urrutia, MD, MS
University of North Carolina Chapel Hill
FacultyHas no relevant financial relationships with ineligible companies to disclose
Michael Policar, MD
University of California San Francisco School of Medicine
FacultyHas no relevant financial relationships with ineligible companies to disclose
Chelsea Polis, PhD
Center for Biomedical Research, Population Council
FacultyHas no relevant financial relationships with ineligible companies to disclose
Joely Pritzker, NP  
Vista Community clinic and Envision SRH
FacultyOrganon – Consultant, Advisor, Speaker 

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and the American Sexual Health Association(ASHA). PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education

PACE designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 7.25 contact hours. 

Designated for 3 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses. 

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as aguideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.